129 related articles for article (PubMed ID: 37923832)
1. High risk of acute pulmonary toxicity with both myeloablative and non-myeloablative total body irradiation-based conditioning for allogeneic stem cell transplantation.
Patel P; Dillon M; Niedzwiecki D; Crowell KA; Horwitz ME; Wang E; Kelsey CR
Bone Marrow Transplant; 2024 Jan; 59(1):150-152. PubMed ID: 37923832
[No Abstract] [Full Text] [Related]
2. Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant.
Baranwal A; Byun J; Ritz E; Kadanagowd A; Murphy D; Marinovic DA; Wang D; Okwuosa T; Katz D; Varma A; Nathan S; Ustun C
Bone Marrow Transplant; 2022 Oct; 57(10):1632-1634. PubMed ID: 35970875
[No Abstract] [Full Text] [Related]
3. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
4. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
5. Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Socié G; Aljurf M; Salmenniemi U; Labussière-Wallet H; Srour M; Kröger N; Zahrani MA; Lioure B; Reményi P; Arat M; Bourhis JH; Helbig G; Tbakhi A; Forcade E; Huynh A; Brissot E; Spirydonidis A; Savani BN; Peric Z; Nagler A; Mohty M
Bone Marrow Transplant; 2023 May; 58(5):506-513. PubMed ID: 36725978
[TBL] [Abstract][Full Text] [Related]
6. Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.
Kelsey CR; Horwitz ME; Chino JP; Craciunescu O; Steffey B; Folz RJ; Chao NJ; Rizzieri DA; Marks LB
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):812-8. PubMed ID: 20932682
[TBL] [Abstract][Full Text] [Related]
7. A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens.
Hamidieh AA; Eslami Shahre Babaki A; Rostami T; Kasaeian A; Koochakzadeh L; Sharifi Aliabadi L; Behfar M; Ghavamzadeh A
Exp Clin Transplant; 2019 Apr; 17(2):243-250. PubMed ID: 30295587
[TBL] [Abstract][Full Text] [Related]
8. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning.
Abugideiri M; Nanda RH; Butker C; Zhang C; Kim S; Chiang KY; Butker E; Khan MK; Haight AE; Chen Z; Esiashvili N
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):349-59. PubMed ID: 26853343
[TBL] [Abstract][Full Text] [Related]
9. Melphalan/total body irradiation-conditioned myeloablative allogeneic hematopoietic cell transplantation for patients with primary plasma cell leukemia.
Landsburg DJ; Vogl DT; Plastaras JP; Stadtmauer EA
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):e225-8. PubMed ID: 25172535
[No Abstract] [Full Text] [Related]
10. Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.
Motohashi K; Fujisawa S; Onizuka M; Kako S; Sakaida E; Shono K; Tatara R; Doki N; Mori T; Sakura T; Aotsuka N; Fuji E; Tomita N; Kawai N; Saitoh T; Usuki K; Taguchi J; Watanabe R; Kobayashi S; Yano S; Kanamori H; Takahashi S; Okamoto S
Bone Marrow Transplant; 2015 Nov; 50(11):1476-9. PubMed ID: 26191948
[No Abstract] [Full Text] [Related]
11. Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
Konishi T; Ogawa H; Najima Y; Hashimoto S; Kito S; Atsuta Y; Wada A; Adachi H; Konuma R; Kishida Y; Nagata A; Yamada Y; Kaito S; Mukae J; Marumo A; Noguchi Y; Shingai N; Toya T; Igarashi A; Shimizu H; Kobayashi T; Ohashi K; Doki N; Murofushi KN
Ann Med; 2022 Dec; 54(1):2616-2625. PubMed ID: 36254468
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation.
Ishida H; Kato M; Kudo K; Taga T; Tomizawa D; Miyamura T; Goto H; Inagaki J; Koh K; Terui K; Ogawa A; Kawano Y; Inoue M; Sawada A; Kato K; Atsuta Y; Yamashita T; Adachi S
Biol Blood Marrow Transplant; 2015 Dec; 21(12):2141-2147. PubMed ID: 26271192
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine versus cyclophospamide in combination with myeloablative total body irradiation as conditioning for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Labopin M; Schroeder T; Swoboda R; Maertens J; Bourhis JH; Grillo G; Salmenniemi U; Hilgendorf I; Kröger N; Poiré X; Cornelissen JJ; Arat M; Savani B; Spyridonidis A; Nagler A; Mohty M
Am J Hematol; 2023 Apr; 98(4):580-587. PubMed ID: 36626592
[TBL] [Abstract][Full Text] [Related]
14. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
15. Peritransplant Serum Albumin Decline Predicts Subsequent Severe Acute Graft-versus-Host Disease after Mucotoxic Myeloablative Conditioning.
Rashidi A; DiPersio JF; Westervelt P; Abboud CN; Schroeder MA; Cashen AF; Pusic I; Romee R
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1137-1141. PubMed ID: 26988741
[TBL] [Abstract][Full Text] [Related]
16. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT.
Pavlů J; Labopin M; Niittyvuopio R; Socié G; Yakoub-Agha I; Wu D; Remenyi P; Passweg J; Beelen DW; Aljurf M; Kröger N; Labussière-Wallet H; Perić Z; Giebel S; Nagler A; Mohty M
J Hematol Oncol; 2019 Oct; 12(1):108. PubMed ID: 31647022
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis.
Edahiro T; Kawase T; Nagoshi H; Fujino K; Toishigawa K; Miyama T; Mino T; Yoshida T; Morioka T; Hirata Y; Noma M; Fujii T; Nishizawa M; Fukushima N; Ichinohe T
Hematology; 2021 Dec; 26(1):186-198. PubMed ID: 33594942
[TBL] [Abstract][Full Text] [Related]
19. Pubertal outcomes of children transplanted with allogeneic stem cells after myeloablative total body irradiation or busulfan: Influence of age and sex is confirmed, while a role of chronic graft-versus-host disease in delayed puberty onset is revealed.
Weinhard S; Wiedemann A; Leheup B; Dalle JH; Lebon Labich B; Pochon C
Pediatr Transplant; 2020 Sep; 24(6):e13773. PubMed ID: 32701220
[TBL] [Abstract][Full Text] [Related]
20. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
Olsson RF; Logan BR; Chaudhury S; Zhu X; Akpek G; Bolwell BJ; Bredeson CN; Dvorak CC; Gupta V; Ho VT; Lazarus HM; Marks DI; Ringdén OT; Pasquini MC; Schriber JR; Cooke KR
Leukemia; 2015 Aug; 29(8):1754-62. PubMed ID: 25772027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
